Pediatric Neuro-Oncology Tumor Board Quarterly Series, December 13, 2021

NTRK mutant gliomas: Diagnosis and Management

Learning Objectives

 

  • Review the emerging role of NTRK fusion oncogenes across pediatric CNS tumors ​
  • Review various NTRK inhibitors currently available for use in pediatric CNS tumors ​
  • Discuss indications for off-study use of NTRK inhibitors for poor prognosis CNS tumor
Course summary
Course opens: 
04/18/2022
Course expires: 
04/09/2027
Cost:
$0.00
Part of: 
Pediatric Neuro-Oncology Tumor Board Quarterly Series - Past Broadcasts
Rating: 
0

Case presenters

Dr. Paul Wood, Monash Health, Australia​

Dr. Nick Gottardo, The University of Western Australia, Australia​

​Neuro-oncologists​

Dr. Susan Chi, Dana-Farber Cancer Institute, USA​

Giles Robinson, St. Jude Children’s Research Hospital, USA​

​Neuro-pathologist

Dr. Cynthia Hawkins, The Hospital for Sick Children, Canada​

​Neurosurgeon

Dr. Chris Xenos, Monash Health, Australia​

​Neuro-radiologist

Dr. Birgit Ertl-Wagner, The Hospital for Sick Children, Canada​

​Radiation Oncologist

Dr. Derek Tsang, The Hospital for Sick Children, Canada

Price

Cost:
$0.00
Please login or register to take this course.

Click the "Take Course" to navigate to the next page.